1Y Close · As of Aug 26, 2026
OSCOTEC operates in the Pharmaceuticals sector.
Legal name: OSCOTECInc.
In fiscal year 2025, OSCOTEC (039200) reported revenue of 99.8 billion KRW, up 193.6% from 34.0 billion KRW a year earlier.
Operating profit was 52.1 billion KRW and net income was 54.4 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 1.37 trillion KRW, with a P/B of 7.35.
These figures can be verified in the DART filing (receipt no. 20260319001005).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 99.8B | 52.1B | 54.4B |
| 2024 | 34.0B | -2.7B | -1.6B |
| 2023 | 5.0B | -32.7B | -28.5B |
Recent Filings
Corporate Briefing (IR)
Large Shareholding Report (General)
Semi-Annual Report (2026.06)
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-20 | Corporate Briefing (IR) |
| 2026-08-14 | Large Shareholding Report (General) |
| 2026-08-14 | Semi-Annual Report (2026.06) |